MarketPeel
Insider Trading Intelligence
MM

Michael C. Mulica

SONM
ACTING CEO · DNA X, INC. · CIK 0001211437
FILING MIX · LIFETIME79%/21%
BUYS
11
SELLS
3
TOTAL VALUE
$73.6K
COMPANIES
1
ACTIVE SINCE
Jun 2021
HOLDINGS NOW
54,071
AVG SELL PX
$1.11
TRADE KIND
SHOWING 14 / 14
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
2 backtested trades · 8 horizons · 2 pending
Forward-return performance of every backtestable P/S trade by Michael C. Mulica, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d2+50.00%-0.05%+1.23%-1.28%-1.28%
14d2+50.00%-3.41%+2.54%-5.95%-5.95%
30d2+50.00%-12.01%+4.67%-16.68%-16.68%
60d2+50.00%-4.85%+4.89%-9.73%-9.73%
90d2+100.00%-36.11%+9.58%-45.69%-45.69%
180d2+100.00%-45.84%+11.81%-57.65%-57.65%
1y2+100.00%-83.81%+22.78%-106.59%-106.59%
2y2(2 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SONM · 54,071 shares · as of Feb 9, 2026
0116,043232,086348,129464,17220222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 11 buys / 3 sellsCOVERAGE · 20 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
50,00054,071Feb 9, 2026Feb 10, 2026View →
SONM
DNA X, INC.
SALE
27,818$1.45$40.3K73,292Apr 23, 2025Apr 25, 2025View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
46,728101,110Mar 31, 2025Apr 2, 2025View →
SONM
DNA X, INC.
SALE
2,559$3.28$8.4K54,382Nov 13, 2024Nov 14, 2024View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
14,12456,941Nov 12, 2024Nov 14, 2024View →
SONM
DNA X, INC.
SALE
36,016$0.69$24.9K428,156Jun 21, 2024Jun 24, 2024View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
78,947464,172Jun 20, 2024Jun 24, 2024View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
66,675385,225Jan 9, 2024Jan 10, 2024View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
89,525318,550Sep 28, 2023Sep 29, 2023View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
47,732229,025Nov 18, 2022Nov 21, 2022View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
85,714181,293Aug 5, 2022Aug 9, 2022View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
13,95395,579Nov 12, 2021Nov 16, 2021View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
75,00081,626Oct 8, 2021Oct 15, 2021View →
SONM
DNA X, INC.
PURCHASEGRANT
Stock grant
66,26566,265Jun 17, 2021Jun 21, 2021View →
Other insiders · SONM
Loading peer insiders…
About this filer
CIK 0001211437
ROLE
Acting CEO
PRIMARY
SONM
COMPANIES
1
ACTIVE SINCE
Jun 2021
MARKETPEEL · /INSIDER/0001211437DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback